By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MD Anderson Cancer Center 

500 Renaissance Drive

St. Joseph  Michigan  49085  U.S.A.
Phone: n/a Fax: n/a



Company News
Moleculin Biotech (MBRX)'s New Drug For The Treatment Of Glioblastoma Nears Clinical Trials At MD Anderson Cancer Center 7/25/2017 7:47:50 AM
Hitachi (HIT) And MD Anderson Cancer Center To Collaborate In Research For Treatment Of Oropharyngeal Cancer Of The Head And Neck 6/7/2017 12:55:49 PM
NovellusDx Registers Another Patent On Their FACT System, Publishes A New Study With Guardant Health And MD Anderson Cancer Center In Cancer Discovery; Was Selected To Present At Biomed, BIO 2017 And ASCO 5/23/2017 6:21:29 AM
Lion Biotech Announces Strategic Alliance With MD Anderson Cancer Center To Conduct Clinical Trials Of Tils In Multiple Solid Tumors 4/20/2017 11:42:44 AM
MD Anderson Cancer Center, Oncora Medical Team Up To Fight Cancer With Precision Medicine Alliance 4/4/2017 12:53:28 PM
PROMETRIKA To Coordinate Phase I Trial For MD Anderson Cancer Center’s Institute For Applied Cancer Science 3/23/2017 7:51:18 AM
MD Anderson Cancer Center And Guardant Health Announce Partnership To Make Comprehensive Liquid Biopsy Part Of Oncology Standard Of Care 1/31/2017 8:06:56 AM
DelMar Pharma Release: Company And MD Anderson Cancer Center Initiate New Phase Two Clinical Trial Of VAL-083 For MGMT-Unmethylated Recurrent Glioblastoma Multiforme (GBM) 1/25/2017 9:52:26 AM
MD Anderson Cancer Center Release: Cancer Center And Deerfield Management Create Vescor LLC To Develop Novel Therapeutics Based On Inhibiting Autophagy For Treatment Of Specific Cancers 1/11/2017 8:17:48 AM
EMD Serono And MD Anderson Cancer Center Enter Three-Year Strategic Collaboration 1/9/2017 7:23:48 AM